ResMed Inc. (LON:0KW4)
London · Delayed Price · Currency is GBP · Price in USD 278.55
+2.63 (0.95%)
At close: Aug 1, 2025
ResMed Market Cap
ResMed has a market cap or net worth of 30.86 billion as of August 1, 2025. Its market cap has increased by 32.64% in one year.
Market Cap
30.86B
Enterprise Value
30.59B
Revenue
3.76B
Ranking
n/a
PE Ratio
30.18
Stock Price
278.55
Market Cap Chart
Since June 2, 1995, ResMed's market cap has increased from 24.33M to 30.86B, an increase of 126,701.94%. That is a compound annual growth rate of 26.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 30.86B | 15.03% |
| Dec 31, 2024 | 26.82B | 35.04% |
| Dec 29, 2023 | 19.86B | -21.72% |
| Dec 30, 2022 | 25.37B | -9.78% |
| Dec 31, 2021 | 28.12B | 24.65% |
| Dec 31, 2020 | 22.56B | 34.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 178.30B |
| GSK plc | 57.24B |
| Haleon | 32.79B |
| Smith & Nephew | 10.17B |
| ConvaTec Group | 4.72B |
| Hikma Pharmaceuticals | 4.40B |
| HUTCHMED (China) | 2.34B |
| Oxford Nanopore Technologies | 1.94B |